Boston Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $367M | Buy |
|
|||||
|
2025
Q1 | $372M | Buy |
|
|||||
|
2024
Q4 | $92.6M | Sell |
|
|||||
|
2024
Q3 | $201M | Sell |
|
|||||
|
2024
Q2 | $210M | Sell |
|
|||||
|
2024
Q1 | $202M | Sell |
|
|||||
|
2023
Q4 | $206M | Sell |
|
|||||
|
2023
Q3 | $219M | Buy |
|
|||||
|
2023
Q2 | $212M | Sell |
|
|||||
|
2023
Q1 | $221M | Sell |
|
|||||
|
2022
Q4 | $304M | Sell |
|
|||||
|
2022
Q3 | $277M | Sell |
|
|||||
|
2022
Q2 | $306M | Buy |
|
|||||
|
2022
Q1 | $311M | Buy |
|
|||||
|
2021
Q4 | $291M | Sell |
|
|||||
|
2021
Q3 | $242M | Sell |
|
|||||
|
2021
Q2 | $802M | Buy |
|
|||||
|
2021
Q1 | $754M | Sell |
|
|||||
|
2020
Q4 | $688M | Sell |
|
|||||
|
2020
Q3 | $596M | Sell |
|
|||||
|
2020
Q2 | $611M | Sell |
|
|||||
|
2020
Q1 | $582M | Buy |
|
|||||
|
2019
Q4 | $635M | Sell |
|
|||||
|
2019
Q3 | $528M | Sell |
|
|||||
|
2019
Q2 | $688M | Buy |
|
|||||
|
2019
Q1 | $522M | Sell |
|
|||||
|
2018
Q4 | $701M | Sell |
|
|||||
|
2018
Q3 | $736M | Sell |
|
|||||
|
2018
Q2 | $695M | Sell |
|
|||||
|
2018
Q1 | $643M | Sell |
|
|||||
|
2017
Q4 | $752M | Sell |
|
|||||
|
2017
Q3 | $693M | Sell |
|
|||||
|
2017
Q2 | $719M | Sell |
|
|||||
|
2017
Q1 | $644M | Buy |
|
|||||
|
2016
Q4 | $263M | Buy |
|
|||||
|
2016
Q3 | $54M | Sell |
|
|||||
|
2016
Q2 | $178M | Sell |
|
|||||
|
2016
Q1 | $359M | Sell |
|
|||||
|
2015
Q4 | $426M | Buy |
|
|||||
|
2015
Q3 | $288M | Sell |
|
|||||
|
2015
Q2 | $410M | Buy |
|
|||||
|
2015
Q1 | $345M | Buy |
|
|||||
|
2014
Q4 | $62.4M | Sell |
|
|||||
|
2014
Q3 | $61.3M | Sell |
|
|||||
|
2014
Q2 | $77.1M | Sell |
|
|||||
|
2014
Q1 | $75.8M | Sell |
|
|||||
|
2013
Q4 | $72.9M | Sell |
|
|||||
|
2013
Q3 | $70.1M | Buy |
|
|||||
|
2013
Q2 | $66.4M | Buy |
|